Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter

فلترة النتائج

Subject : cancer research Subject : carcinoma, hepatocellular Subject : cell proliferation Subject : immunology Subject : liver neoplasms Subject : medicine.diagnostic_test Subject : medicine.disease Subject : survival rate فلترة بواسطة : مؤلف
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of Sirtuin 7 via microRNA-3666.

  • Authors : Li Y; Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Shi H

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2020 Jul; Vol. 47 (7), pp. 1291-1300. Date of Electronic Publication: 2020 Feb 27.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Micro-RNA-21 rs1292037 A>G polymorphism can predict hepatocellular carcinoma prognosis (HCC), and plays a key role in cell proliferation and ischemia-reperfusion injury (IRI) in HCC cell model of IRI.

  • Authors : Wu C; Department of Infectious Diseases, Linyi Central Hospital, Linyi, China. E-mail. .; Tang G

Subjects: Polymorphism, Genetic*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology

  • Source: Saudi medical journal [Saudi Med J] 2020 Apr; Vol. 41 (4), pp. 383-392.Publisher: Medical Services Department, Saudi Arabian Armed Forces, Ministry Of Defence And Aviation Country of Publication: Saudi Arabia NLM ID: 7909441

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22

Subjects: cell proliferation; miR-34b; nasopharyngeal carcinoma

  • Source: OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 1525-1534 (2016)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.

  • Authors : Liu K; a The Second Clinical Medical School of Lanzhou University, Lanzhou, Gansu Province, 730030; China.

Subjects: Apoptosis/Apoptosis/Apoptosis/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Cell Cycle Proteins/Cell Cycle Proteins/Cell Cycle Proteins/*genetics

  • Source: Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2018 Dec; Vol. 96 (12), pp. 1246-1254. Date of Electronic Publication: 2018 Aug 08.Publisher: Canadian Science Publishing Country of Publication: Canada NLM ID: 0372712 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma.

  • Authors : Wu B; Cell Engineering Research Centre & Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, 169 Changle West Road, Xi'an, 710032, P. R. China. .; Wang Y

Subjects: Basigin/Basigin/Basigin/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology ; Cell Movement/Cell Movement/Cell Movement/*genetics

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2015 Oct 06; Vol. 34, pp. 110. Date of Electronic Publication: 2015 Oct 06.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

75P PD-L1 expression and TMB guided first-line sintilimab monotherapy for advanced NSCLC in a multi-center, phase II umbrella trial (CTONG 1702)

Subjects: Cancer Research; Oncology

  • Source: ESMO Open ; volume 9, page 102654 ; ISSN 2059-7029

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

194MO Phase II study of low-dose radiation (LDRT) plus durvalumab (D) and etoposide/platinum (EP) as first-line treatment in ES-SCLC (LEAD): Efficacy and safety results

Subjects: Cancer Research; Oncology

  • Source: ESMO Open ; volume 9, page 102767 ; ISSN 2059-7029

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

13P Tislelizumab (TIS) plus chemotherapy (chemo) with or without bevacizumab (beva) for patients with EGFR-mutated nonsquamous non-small cell lung cancer (nsq-NSCLC) after progression on EGFR tyrosine kinase inhibitor (TKI) therapy

Subjects: Cancer Research; Oncology

  • Source: ESMO Open ; volume 9, page 102592 ; ISSN 2059-7029

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

139P Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: A systematic review and network meta-analysis

Subjects: Cancer Research; Oncology

  • Source: ESMO Open ; volume 9, page 102726 ; ISSN 2059-7029

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

65P Preliminary results of a phase II multicenter, open-label study of fruquintinib monotherapy as third-line treatment in advanced pancreatic cancer

Subjects: Cancer Research; Oncology

  • Source: ESMO Open ; volume 9, page 102294 ; ISSN 2059-7029

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×